A/S BI BIOMEDICAL VENTURE ANNEX KOMPLEMENTAR: Financial statements 2017
CVR: 27908047
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
A/S BI BIOMEDICAL VENTURE ANNEX KOMPLEMENTAR (CVR 27908047) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -21,000 and a net result of DKK -43,000 compared with DKK -255,000 the year before. Equity in the 2017 report amounted to DKK 2,748,000. The solvency ratio was 99.7%.
- Gross Profit
- DKK -21,000
- Profit/Loss
- DKK -43,000
- Equity
- DKK 2,748,000
- Total Assets
- DKK 2,757,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | -21K | -43K | 2.7M | - |
| 2016 | - | -17K | -255K | 2.8M | - |
| 2015 | - | -28K | 700K | 3M | - |
| 2014 | - | -16K | 104K | 2.3M | - |
| 2013 | - | -16K | -196K | 2.2M | - |
Official annual report
Keep an eye on A/S BI BIOMEDICAL VENTURE ANNEX KOMPLEMENTAR
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
A/S BI BIOMEDICAL VENTURE ANNEX KOMPLEMENTAR has published its annual report for 2016. Gross profit came to DKK -17,000, and the net result was DKK -255,000.
About A/S BI BIOMEDICAL VENTURE ANNEX KOMPLEMENTAR
A/S BI BIOMEDICAL VENTURE ANNEX KOMPLEMENTAR is a Danish company of the type Aktieselskab based in København K, founded in 2004. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Ahmet Turan Kayhan. The board consists of Andrea Panzieri (chair), Allan Funk Nissen and Ahmet Turan Kayhan. The company is owned by BI HOLDING A/S. According to the 2023 annual report, the company had an average of 0 employees. In 2025, the company reported a net result of DKK -3,000 compared with DKK 2,000 the year before. Equity in the 2025 report amounted to DKK 2,482,000.
